Largest pure-play peptide CDMO. CHF approximately 400M capex 2024 to 2025 across Bubendorf, Vista, and Torrance to expand solid-phase peptide synthesis capacity for GLP-1 demand.
Largest pure-play peptide CDMO. CHF approximately 400M capex 2024 to 2025 across Bubendorf, Vista, and Torrance to expand solid-phase peptide synthesis capacity for GLP-1 demand.
Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling: